Metraipolis › archive › dc_da1c37811541

Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma — Europe PMC PMID:41827672

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41827672
DOI
10.3390/cancers18050737
License (as archived)
solo-consultazione
Archived
2026-10-07T19:48:53.548Z
SHA-256 of the archived text
eaaab3344c2580a20e9c351e0a32101db77e12447787bbce77eaa6315b07061b
Stable URL of this page
https://metraipolis.com/documento/dc_da1c37811541

How to cite

Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma — Europe PMC PMID:41827672 — Europe PMC (en), https://europepmc.org/article/MED/41827672 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da1c37811541 (Metraipolis archive dc_da1c37811541, sha256 eaaab3344c2580a20e9c351e0a32101db77e12447787bbce77eaa6315b07061b)
BibTeX
@misc{dcda1c37811541,
  title = {Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma — Europe PMC PMID:41827672},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41827672},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da1c37811541; sha256 eaaab3344c2580a20e9c351e0a32101db77e12447787bbce77eaa6315b07061b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41827672. Agents can read the archived copy with the MCP tool read_document.